Suchen Sie nach Informationen zu Astellas Firmenzentrale? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.


Astellas Pharma US | Changing Tomorrow | Home

    https://www.astellas.com/us/
    Learn more about our commitment to patients and available resources. Call us at (800) 888-7704, M-F, 8AM-7PM CT.

Investor Relations | Astellas Pharma Inc.

    https://www.astellas.com/en/investors
    Stock & Rating Information. Year-end dividend - March 31 Interim dividend - September 30 Note: In accordance with the Company's Articles of Incorporation, if cash dividends are not claimed for three (3) full years from the day of commencement of payment, the Company shall be relieved of the obligation to make such payment. Read More.

Astellas Established Markets Commercial (EST-C) | Pharma

    https://www.astellas.com/eu/
    At Astellas, the health and well-being of our patients, employees and communities is our primary focus and we have taken special steps to respond to the COVID-19 pandemic. Find out more. ABOUT US CHANGING TOMORROW™ is the ethos that guides everything that Astellas does, and is the measure by which we judge our success. Find out more ...

Astellas Home page | Astellas Pharma Inc.

    https://www.astellas.com/en/
    Astellas was established in 2005 through merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical CO., Ltd. and has a rich history spanning over 100 years. Annual Report 2021. Annual Report 2021 Integrated with the CSR report.

Subsidiaries & Locations | Astellas Pharma Inc.

    https://www.astellas.com/en/about/subsidiaries-and-locations
    Regional headquarters (Astellas EMEA operations) Astellas Pharma Europe Ltd. R&D and manufacturing bases Astellas Pharma Europe B.V. (R&D and manufacturing, Netherlands) Astellas Ireland Co., Limited (Development and manufacturing, Ireland) Sales bases Astellas Pharma Ges.m.b.H (Austria) Astellas Pharma B.V. (Belgium) Astellas Pharma s.r.o ...

Corporate Information | Astellas (EST-C)

    https://www.astellas.com/eu/about/corporate-information
    Astellas Established Markets-Commercial (EST-C) operates in 37 countries, speaking 23 main languages, and is a regional business of Tokyo-based Astellas Pharma Inc. The EST-C region headquarters are based in the UK, and support the affiliate teams across Europe, Australia and Canada, working in collaboration with the Manufacturing and Medical ...

Astellas.nl

    https://www.astellas.com/nl/
    Official website for Astellas Pharma EMEA. Learn about Corporate Information, Research & Development and Corporate Social Responsibility (CSR).

About | Astellas Established Markets Commercial (EST-C)

    https://www.astellas.com/eu/about/
    About Established Markets Commercial (EST-C) Astellas Established Markets-Commercial (EST-C) is a regional centre of excellence in healthcare …

Procurement | Astellas (EST-C)

    https://www.astellas.com/eu/procurement/
    The Astellas (EST-C) procurement page provides downloadable general terms and conditions and disclaimer to purchase orders documents for each region.

Contact | Astellas Established Markets Commercial (EST-C)

    https://www.astellas.com/eu/contact-us/
    Contact Form. Kindly note that queries submitted are only monitored Monday to Friday between UK business hours (9am-5pm). Queries are not monitored over the weekends. For queries received during public holidays or weekends, these will be reviewed on the first day after returning to the office. In the event of a medical emergency please contact ...

Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Astellas Firmenzentrale gefunden haben.